Поисковый запрос: (<.>S=МИАЛГИИ<.>) |
Общее количество найденных документов : 48
Показаны документы с 1 по 20
|
|
1.
| Granges G. Pressure Pain Threshold in Pain-Free Subjects, in Patients with Chronic Regional Pain Syndromes, and in Patients with Fibromyalgia Syndrome // Headache Quart., 1993. Vol. 4, N 4.-С.372
|
2.
| Antineurtrophil cytoplasmic antibodies and the eosinophilia myalgia syndrome // Ann. Rheum. Diseases, 1995. Vol. 54, N 3.-С.233-234
|
3.
| Antineurtrophil cytoplasmic antibodies and the eosinophilia myalgia syndrome // Ann. Rheum. Diseases, 1995. Vol. 54, N 3.-С.233-234
|
4.
| Myalgies chroniques dans la borreliose de Lyme (BL): Recherche d'ADN de Borrelia Burgdorferi dans le muscle par amplification genique (PCR) // Rev. rhum. Ed. fr., 1994. Vol. 61, N 10.-С.778
|
5.
| Myalgies chroniques dans la borreliose de Lyme (BL): Recherche d'ADN de Borrelia Burgdorferi dans le muscle par amplification genique (PCR) // Rev. rhum. Ed. fr., 1994. Vol. 61, N 10.-С.778
|
6.
| Update: Analysis of L-tryptophan for the etiology of Eosinophilia-Myalgia syndrome // MMWR: Morbid. and Mortal. Weekly Rept, 1990. Vol. 39, N 43.-С.789-790
|
7.
| Antiphospholipid antibodies in patients with eosinophilia myalgia and toxic oil syndrome // J. Rheumatol., 1997. Vol. 24, N 1.-С.69-72
|
8.
| Antiphospholipid antibodies in patients with eosinophilia myalgia and toxic oil syndrome // J. Rheumatol., 1997. Vol. 24, N 1.-С.69-72
|
9.
| Sullivan Elizabeth A. Eosinophilia-Myalgia syndrome among the non-L-tryptophan user and pre-epidemic cases // J. Rheumatol., 1996. Vol. 23, N 10.-С.1784-1787
|
10.
| Wagner Krystn R. Diagnostic bias in clinical decision making: An example of L-tryptophan and the diagnosis of eosinophilia-myalgia syndrome // J. Rheumatol., 1996. Vol. 23, N 12.-С.2079-2085
|
11.
| Silver Richard M. Pathonphysiology of the eosinophilia-myalgia syndrome // J. Rheumatol., 1996. Vol. 23, Suppl. n 46.-С.26-36
|
12.
| Pincus Eosinophilia-myalgia syndrome: Patient status 2-4 years after onset // J. Rheumatol., 1996. Vol. 23, Suppl. n 46.-С.19-25
|
13.
| Analysis of centers for disease control and prevention criteria for the eosinophilia-myalgia syndrome in a geographically defined population // J. Rheumatol., 1996. Vol. 23, Suppl. n 46.-С.73-80
|
14.
| Hertzman Phillip A. Criteria for the definition of the eosinophilia-myalgia syndrome // J. Rheumatol., 1996. Vol. 23, Suppl. n 46.-С.7-12
|
15.
| Clauw Daniel J. Animal models of the eosinophilia-myalgia syndrome // J. Rheumatol., 1996. Vol. 23, Suppl. n 46.-С.93-98
|
16.
| Belongia Edward A. The Eosinophilia-Myalgia Syndrome revisited // J. Rheumatol., 1996. Vol. 23, N 10.-С.1682-1685
|
17.
| Fibromyalgia, psychiatric disorders, and assessment of the longterm outcome of eosinophilia-myalgia syndrome // J. Rheumatol., 1996. Vol. 23, Suppl. n 46.-С.37-43
|
18.
| A diagnostic algorithm for distinguishing the eosinophilia-myalgia syndrome from fibromyalgia and chronic myofascial pain // J. Rheumatol., 1996. Vol. 23, Suppl. n 46.-С.13-18
|
19.
| Herman Phillip A. The Eosinophilia-Myalgia Syndrome: Opportunities realized and missed // J. Rheumatol., 1996. Vol. 23, N 10.-С.1679-1681
|
20.
| Clauw Daniel J. The eosinophilia-myalgia syndrome: What we know, what we think we know, and what we need to know // J. Rheumatol., 1996. Vol. 23, Suppl. n 46.-С.2-6
|
&uf('+1W2226#',v2226), ?>
|
|